Generic Name and Formulations:
Lodoxamide tromethamine 0.1%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for ALOMIDE:
Vernal conjunctivitis, keratoconjunctivitis, or keratitis.
Adults and Children:
<2yrs: not recommended. ≥2yrs: 1–2 drops 4 times daily for up to 3 months.
Do not wear soft contact lenses during treatment.
Pregnancy (Cat.B). Nursing mothers.
Mast cell stabilizer.
Transient burning, stinging or discomfort, pruritus, blurred vision, dry eye, discharge, hyperemia, crystalline deposits, foreign body sensation, headache.
Clinical Pain Advisor Articles
- Brain Plasticity in Patients With Complex Regional Pain Syndrome
- Chronic Pain Associated With Traumatic Brain Injury: Causes and Management
- Perturbation-Based Rehabilitation Effective for Chronic Low Back Pain
- Migraine Frequency Correlated With Depression and Anxiety
- IBS-Associated Chronic Pain: Formulation of Core Diagnostic Criteria
- Cannabis Use Associated With Aberrant Drug Behaviors
- Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse
- Independent Pharmacies Expanding Services Available to Patients
- Ketamine Exhibits Effective Pain Relief for Refractory Headaches
- Pain In Elite Athletes: IOC Recommendations on Contributing Factors and Treatment Approach
- Naproxen Plus Muscle Relaxants vs Naproxen Monotherapy for Low Back Pain
- Pain Processing: Examining the Role of Oxytocin
- Short- vs Long-Acting Opioids for Osteoarthritis Pain
- Extended-Release Naltrexone Injections Reduce Opioid Dependence
- Depressive Symptoms in Medical Interns Increased With Work-Family Conflicts